HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: The experience of the Turkish Pediatric Bone Marrow Transplantation Group

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages 846-851

  Yesilipek, M Akif ^a   Ertem, Mehmet ^b   Cetin, Mualla ^c   Ãniz, Haldun ^d   Kansoy, Savas ^e   Tanyeli, Atila ^f   Anak, Sema ^g   Kurekci, Emin ^h   Hazar, Volkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Tepecik State Children Hospital   (Turkey)

^e EGE UNIVERSITY   (Turkey)

^f CUKUROVA UNIVERSITY   (Turkey)

^g ISTANBUL UNIVERSITY   (Turkey)

^h GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

beta thalassemia; hematopoietic stem cell transplantation; matched family donor

Indexed keywords

FERRITIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT APLASIA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; SCHOOL CHILD; SURGICAL MORTALITY; THALASSEMIA MAJOR; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; TIME FACTORS; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 84868695793     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01778.x     Document Type: Article

References (24)

1. Thomas ED, Buckner CD, Sanders JE, et al., Marrow transplantation for thalassemia. Lancet 1982: 2: 227-229.
2. Gaziev J, Lucarelli G,. Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 2003: 15: 24-31.
3. Lucarelli G, Galimberti M, Polchi P, et al., Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990: 322: 417.
4. Ghavamzadeh A, Nasseri P, Eshraghian MR, et al., Prognostic factors in bone marrow transplantation for beta thalassemia major: Experiences from Iran. Bone Marrow Transplant 1998: 22: 1167-1169.
5. Ramzi M, Nourani H, Zakernia M, Hamidian Jahromi AR,. Hematopoietic stem cell transplantation for beta-thalassemia major: Experience in south of Iran. Transplant Proc 2004: 36: 2509-2510.
6. Lawson SE, Roberts IA, Amrolia P, Dokal I, Szydlo R, Darbyshire PJ,. Bone marrow transplantation for beta-thalassaemia major: The UK experience in two paediatric centres. Br J Haematol 2003: 120: 289-295.
7. Mahmoud H, El-Haddad A, Fahmy O, et al., Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant 2008: 42 (Suppl 1): S76-S80.
8. Chandy M, Srivastava A, Dennison D, Mathews V, George B,. Allogeneic bone marrow transplantation in the developing world: Experience from a center in India. Bone Marrow Transplant 2001: 27: 785-790.
9. Di Bartolomeo P, Santarone S, Di Bartolomeo E, et al., Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol 2008: 83: 528-530.
10. Lucarelli G, Andreani M, Angelucci E,. The cure of the thalassemia with bone marrow transplantation. Bone Marrow Transplant 2001: 28 (Suppl 1): S11-S13.
11. Sabloff M, Chandy M, Wang Z, et al., HLA-matched sibling bone marrow transplantation for {beta}-thalassemia major. Blood 2011: 117: 1745-1750.
12. Devergie A,. Graft versus host disease. In:, Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T, eds. Bone Marrow Transplantation, EBMT Handbook, Revised Edition. Paris, France: European School of Haematology, 2008: pp. 218-234.
13. Altay Ã,. The frequency and distribution pattern of Ã-thalassemia mutations in Turkey. Turk J Haematol 2002: 19: 309-315.
14. Scalone L, Mantovani LG, Krol M, et al., Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: The ITHACA study. Curr Med Res Opin 2008: 24: 1905-1917.
15. Angelucci E, Baronciani D,. Allogeneic stem cell transplantation for thalassemia major. Haematologica 2008: 93: 1780-1784.
16. Delea TE, Edelsberg J, Sofrygin O, et al., Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: A literature review. Transfusion 2007: 47: 1919-1929.
17. Sabloff M, Chandy M, Wang Z, et al., HLA-matched sibling bone marrow transplantation for beta thalassemia major. Blood 2011: 117: 1745-1750.
18. Gaziev J, Sodani P, Lucarelli G, et al., Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Bone Marrow Transplant 2008: 42: 397-404.
19. La Nasa G, Argiolu F, Giardini C, et al., Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005: 1054: 186-195.
20. Hao WG, Sun X, Liu S, Zhao Z, Chen ZX,. Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children. Zhongguo Dang Dai Er Ke Za Zhi 2009: 11: 546-548.
21. Jaing TH, Hung IJ, Yang CP, et al., Unrelated cord blood transplantation for thalassaemia: A single-institution experience of 35 patients. Bone Marrow Transplant 2012: 47: 33-39.
22. Pakakasama S, Hongeng S, Chaisiripoomkere W, Chuansumrit A, Sirachainun N, Jootar S,. Allogeneic peripheral blood stem cell transplantation in children with homozygous beta-thalassemia and severe beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol 2004: 26: 248.
23. Yesilipek MA, Hazar V, Kupesiz A, Kizilors A, Uguz A, Yegin O,. Peripheral blood stem cell transplantation in children with beta-thalassemia. Bone Marrow Transplant 2001: 28: 1037-1040.
24. Ghavamzadeh A, Iravani M, Ashouri A, et al., Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major. Biol Blood Marrow Transplant 2008: 14: 301-308.